GIORDANI, BARBARA
 Distribuzione geografica
Continente #
EU - Europa 3.550
AS - Asia 3.352
NA - Nord America 3.082
AF - Africa 285
SA - Sud America 181
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.464
Nazione #
US - Stati Uniti d'America 3.028
IT - Italia 1.549
CN - Cina 1.115
SG - Singapore 1.053
GB - Regno Unito 538
DE - Germania 384
VN - Vietnam 383
HK - Hong Kong 294
SE - Svezia 238
IN - India 172
KR - Corea 145
NL - Olanda 141
RU - Federazione Russa 139
BR - Brasile 137
FR - Francia 125
CI - Costa d'Avorio 102
IE - Irlanda 95
FI - Finlandia 70
UA - Ucraina 66
TG - Togo 58
ZA - Sudafrica 52
ID - Indonesia 40
JP - Giappone 35
SC - Seychelles 35
CA - Canada 31
CH - Svizzera 31
EE - Estonia 31
JO - Giordania 28
BE - Belgio 27
BG - Bulgaria 25
AR - Argentina 21
NG - Nigeria 21
IR - Iran 17
PL - Polonia 15
AT - Austria 13
ES - Italia 13
TR - Turchia 13
MX - Messico 11
AU - Australia 9
CZ - Repubblica Ceca 9
MY - Malesia 9
NO - Norvegia 9
BD - Bangladesh 8
EC - Ecuador 8
TH - Thailandia 8
HR - Croazia 7
CL - Cile 6
IQ - Iraq 6
IL - Israele 5
RO - Romania 5
DK - Danimarca 4
GR - Grecia 4
LB - Libano 4
NZ - Nuova Zelanda 4
TN - Tunisia 4
CO - Colombia 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
EG - Egitto 3
PH - Filippine 3
UY - Uruguay 3
UZ - Uzbekistan 3
AL - Albania 2
BZ - Belize 2
HU - Ungheria 2
KZ - Kazakistan 2
PA - Panama 2
PK - Pakistan 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BW - Botswana 1
BY - Bielorussia 1
CM - Camerun 1
CU - Cuba 1
CV - Capo Verde 1
ET - Etiopia 1
EU - Europa 1
GL - Groenlandia 1
IS - Islanda 1
KE - Kenya 1
KW - Kuwait 1
LT - Lituania 1
LV - Lettonia 1
MU - Mauritius 1
NI - Nicaragua 1
PE - Perù 1
PR - Porto Rico 1
PT - Portogallo 1
PY - Paraguay 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
Totale 10.464
Città #
Singapore 672
Southend 465
Ashburn 395
Bologna 304
Hefei 302
Hong Kong 285
Chandler 245
Ann Arbor 167
Santa Clara 152
Seoul 140
Dallas 123
Beijing 122
Fairfield 117
Frankfurt am Main 117
Abidjan 102
Princeton 102
Boardman 97
Dong Ket 97
Dublin 92
Milan 86
Los Angeles 82
Wilmington 82
Seattle 78
Houston 70
New York 61
Ho Chi Minh City 58
Lomé 58
Rome 56
Cambridge 52
Turin 52
Woodbridge 52
Padova 48
Nanjing 47
Hanoi 46
Helsinki 43
Redmond 42
Westminster 42
Berlin 41
Shanghai 34
Medford 33
Tukwila 32
Dearborn 31
Bengaluru 29
Buffalo 29
Munich 29
Amman 28
Jinan 27
Tokyo 26
Guangzhou 25
Redondo Beach 25
Sofia 25
Jakarta 24
Naples 24
Abeokuta 21
Florence 21
Bern 20
Shenyang 20
Tianjin 20
Redwood City 19
Nanchang 18
Brussels 17
Saint Petersburg 17
Cesena 16
Changsha 16
Zhengzhou 16
Catania 15
Toronto 15
Verona 15
Forlì 14
Genoa 14
São Paulo 14
Chicago 13
Lappeenranta 13
Cagliari 12
Des Moines 12
Hebei 12
London 12
Boston 11
Falkenstein 11
Modena 11
Amsterdam 10
Boydton 10
Ningbo 10
Nuremberg 10
San Francisco 10
Tongling 10
Turku 10
Brooklyn 9
Hangzhou 9
Montreal 9
Palermo 9
Parma 9
San Diego 9
Brescia 8
Hyderabad 8
Rio de Janeiro 8
Roubaix 8
Shenzhen 8
Tromsø 8
Venezia 8
Totale 6.208
Nome #
Accuratezza della spettrometria di massa MALDI-TOF nell’identificazione di specie di lattobacilli 636
NUOVI APPROCCI PER L’IDENTIFICAZIONE DI SPECIE DI LATTOBACILLI: RUOLO DELLA SPETTROMETRIA DI MASSA MALDI-TOF E DELLA METABOLOMICA 431
BIFIDOBACTERIUM BREVE BC104: ORALLY ADMINISTERED VAGINAL PROBIOTIC FOR PREVENTING GENITAL AND URINARY TRACT INFECTIONS 297
Lactobacillus crispatus BC5 Interferes With Chlamydia trachomatis Infectivity Through Integrin Modulation in Cervical Cells. 253
Insights Into Vaginal Bacterial Communities and Metabolic Profiles of Chlamydia trachomatis Infection: Positioning Between Eubiosis and Dysbiosis 245
Biosurfactant from vaginal Lactobacillus crispatus BC1 as a promising agent to interfere with Candida adhesion 222
Vaginal Lactobacilli Supernatants Protect from Herpes Simplex Virus Type 1 Infection in Cell Culture Models 188
Design and validation of a DNA-microarray for phylogenetic analysis of bacterial communities in different oral samples and dental implants 183
Biosurfactant for solubilization and skin permeation enhancement of hydrocortisone 180
Exopolysaccharides from vaginal lactobacilli modulate microbial biofilms 178
Liposomes containing biosurfactants isolated from Lactobacillus gasseri exert antibiofilm activity against methicillin resistant Staphylococcus aureus strains 176
Anti-bacterial activity of vaginal lactobacilli against Chlamydia trachomatis 173
Novel approaches for the taxonomic and metabolic characterization of lactobacilli: Integration of 16S rRNA gene sequencing with MALDI-TOF MS and 1H-NMR 172
Novel mixed vesicles containing lactobacilli biosurfactants for vaginal delivery of econazole nitrate 172
Lactobacilli extracellular vesicles: potential postbiotics to support the vaginal microbiota homeostasis 169
OralArray: a new phylogenetic DNA-microarray to characterize the oral microbiota 168
Antioxidant and Functional Features of Pre-Fermented Ingredients Obtained by the Fermentation of Milling By-Products 167
Vaginal Lactobacillus strains interfere with Chlamydia trachomatis infection 155
Vaginal Lactobacillus Impair Candida Dimorphic Switching and Biofilm Formation 150
Biosurfactant loaded vesicles for the local treatment of Staphylococcus aureus skin infections 149
Studio in vitro dell’attività antimicrobica di lattobacilli vaginali nei confronti di Chlamydia trachomatis. 148
Approcci innovativi per l’identificazione di specie di lattobacilli: studio dei metaboliti mediante spettrometria di risonanza magnetica (1H-RMN) 148
Protective Mechanisms of Vaginal Lactobacilli against Sexually Transmitted Viral Infections 144
Limosilactobacillus vaginalis Exerts Bifidogenic Effects: A Novel Postbiotic Strategy for Infant Prebiotic Supplementation 142
Dairy bioactives and functional ingredients with skin health benefits 142
Isolation and characterization of biosurfactants produced by Lactobacillus gasseri of vaginal origin 139
Vaginal Bifidobacterium breve for preventing urogenital infections: Development of delayed release mucoadhesive oral tablets 135
Lactobacilli cell-free supernatants: Potential green and natural enhancers for nose-to-brain delivery of small hydrophilic molecules 130
Lactobacillus crispatus BC1 Biosurfactant Delivered by Hyalurosomes: An Advanced Strategy to Counteract Candida Biofilm 127
Mucoadhesive and mucopenetrating chitosan nanoparticles for glycopeptide antibiotic administration 126
Anti-candida activity of hyaluronic acid combined with lactobacillus crispatus lyophilised supernatant: A new antifungal strategy 125
Development and validation of a new phylogenetic DNA-microarray specific for the oral microbiota 123
Freeze-Dried Matrices Based on Polyanion Polymers for Chlorhexidine Local Release in the Buccal and Vaginal Cavities 121
THE HEALTH-PROMOTING EFFECT OF EXTRACELLULAR VESICLES RELEASED BY VAGINAL LACTOBACILLI 120
Association of mucoadhesive polymeric matrices and liposomes for local delivery of miconazole: A new approach for the treatment of oral candidiasis 120
Functional and biochemical characterization of pre-fermented ingredients obtained by the fermentation of durum wheat by-products 117
Characterization of anti-Candida activity of vaginal lactobacilli 117
Interaction of vaginal Lactobacillus strains with HeLa cell plasma membrane. 117
New Spanish Broom dressings based on Vitamin E and Lactobacillus plantarum for superficial skin wounds 117
Orange Peel Lactiplantibacillus plantarum: Development of A Mucoadhesive Nasal Spray with Antimicrobial and Anti-Inflammatory Activity 116
Biotechnological Valorization of Brewer's Spent Grains and Grape Pomace to Obtain Functional Ingredients for Food Formulations 115
Prebiotic Activity of Vaginal Lactobacilli on Bifidobacteria: from Concept to Formulation 114
Utilizing liposomal quercetin and gallic acid in localized treatment of vaginal Candida infections 113
Ondansetron Buccal Administration for Paediatric Use: A Comparison Between Films and Wafers 111
Lactobacillus strains isolated from vaginal microbiota of healthy women inhibit Candida growth and adherence 109
Role of vaginal lactobacilli in counteracting Chlamydia trachomatis infectivity in an in vitro model 109
Effect of Lactobacillus biosurfactant on hydrocortisone solubilization and skin permeation 109
Lactobacilli cell-free supernatants can improve cromolyn nasal absorption 108
The vaginal microbiome of healthy, bacterial vaginosis and Chlamydia trachomatis-infected women 107
Biosurfactant-based mixed vesicles for vaginal delivery of econazole 106
Lactobacillus crispatus BC1 Biosurfactant Counteracts the Infectivity of Chlamydia trachomatis Elementary Bodies 105
Influence of lactobacillus biosurfactants on skin permeation of hydrocortisone 104
Preliminary results on the preparation of Spanish Broom, flax and hemp wound dressings based on 18-β-glycyrrhetinic acid-cyclodextrin inclusion complexes 103
Novel approaches for the species-level identification of lactobacilli: integration of 16S rRNA gene sequencing with MALDI-TOF MS and 1H-NMR 102
A new wound dressing based on Spanish Broom fibers for the local release of Vitamin E and Lactobacillus plantarum 101
Lactobacillus Biofilms Influence Anti-Candida Activity 101
Development of chitosan nanoparticles with mucoadhesive/mucopenetrating properties 100
null 96
Orally administered vaginal Bifidobacterium Breve BC104 for preventing genital and urinary tract infections 96
null 94
Interaction of vaginal Lactobacillus strains with HeLa cells plasma membrane 93
Freeze-dried matrices for chlorhexidine release in the buccal and vaginal cavities 90
Vaginal lactobacilli exert prebioTIc effects towards gut bifidobacteria 88
New liposomes containing natural molecules for treatment of vaginal diseases 88
Lecithin and Chitosan as Building Blocks in Anti-Candida Clotrimazole Nanoparticles 87
Human Lactobacillus Biosurfactants as Natural Excipients for Nasal Drug Delivery of Hydrocortisone 80
New Spanish Broom’s wound dressing loaded with Vitamin E and Lactobacillus plantarum for skin wounds 78
Lactobacillus biosurfactant: a green excipient for the preparation of vaginal mixed vesicles 73
Novel mixed vesicles containing lactobacilli biosurfactant for vaginal delivery of an anti-Candida agent 73
Lactobacillus biosurfactant as natural excipient for nasal drug delivery 73
Exopolysaccharides released by vaginal Lactobacillus strains: chemical characterization and modulation of biofilm formation. 72
Vaginal Lactobacilli interfere with Chlamydia trachomatis infection process in HeLa cells. 71
Sistemi gelificanti in situ per la veicolazione intranasale e naso-cervello di farmaci con diverse proprietà fisico-chimiche 69
Candida spp. biofilm formation is inhibited by vaginal Lactobacillus supernatants 69
Impact of Lactobacillus exopolysaccharides on vaginal microbial biofilms 65
LACTOBACILLUS VAGINALIS BC17 DERIVATIVES EXERT BIFIDOGENIC ACTIVITY 64
Vaginal Lactobacillus gasseri biosurfactant: a novel bio- and eco-compatible anti-Candida agent 59
Lactobacilli as Anti-biofilm Strategy in Oral Infectious Diseases: A Mini-Review 57
Tailored anti-biofilm activity - Liposomal delivery for mimic of small antimicrobial peptide 52
Liposomes-in-chitosan hydrogel boosts potential of chlorhexidine in biofilm eradication in vitro 52
Nanocarriers for the delivery of Lactobacillus crispatus BC1 biosurfactant: alternative strategies to fight Candida biofilms 48
null 47
The vaginal microbiome of healthy, bacterial vaginosis and Chlamydia trachomatis-infected women 46
Functional and Safety Profile of Limosilactobacillus vaginalis and Development of Oral Fast-Disintegrating Tablets for Gut Microbiota Modulation 35
Totale 10.770
Categoria #
all - tutte 29.432
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.432


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021618 0 0 0 0 0 24 36 52 120 77 44 265
2021/20221.022 83 57 55 27 103 57 39 75 46 82 215 183
2022/20231.483 137 185 79 177 111 106 29 87 256 104 105 107
2023/2024911 57 73 64 98 92 174 60 72 42 64 59 56
2024/20252.543 122 228 237 186 318 120 316 146 62 164 193 451
2025/20262.671 429 595 527 430 474 216 0 0 0 0 0 0
Totale 10.770